Serometrix
Biotechnology, 732 Pittsford Victor Rd, Pittsford, New York, 14534, United States, 1-10 Employees
Phone Number: 15*********
Who is SEROMETRIX
Serometrix is an in silico Drug Discovery company that delivers novel families of targeted lead stage molecules for development by strategic partners. The proprietary Serometrix discovery...
Read More
- Headquarters: 732 Pittsford Victor Rd, Pittsford, New York, 14534, United States
- Date Founded: 2004
- Employees: 1-10
- Revenue: $1 Million to $5 Million
- Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731 | NAICS Code: 541715 | Show More
Does something look wrong? Fix it. | View contact records from SEROMETRIX
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Serometrix
Answer: Serometrix's headquarters are located at 732 Pittsford Victor Rd, Pittsford, New York, 14534, United States
Answer: Serometrix's phone number is 15*********
Answer: Serometrix's official website is https://serometrix.com
Answer: Serometrix's revenue is $1 Million to $5 Million
Answer: Serometrix's SIC: 8731
Answer: Serometrix's NAICS: 541715
Answer: Serometrix has 1-10 employees
Answer: Serometrix is in Biotechnology
Answer: Serometrix contact info: Phone number: 15********* Website: https://serometrix.com
Answer: Serometrix is an in silico Drug Discovery company that delivers novel families of targeted lead stage molecules for development by strategic partners. The proprietary Serometrix discovery platform identifies and emulates wild type protein interactions, providing detailed biological knowledge and delivering synthetic lead stage molecules for licensure and/or co-development. The company offers significant value to the drug discovery and development process by providing: * a proprietary in silico method for identifying protein-protein interaction "hot spots", complementing x-ray crystallography and antibody mapping techniques * a proprietary in silico method that yields initial regulatory prototype compounds (wild type ligands) for orthosteric and allosteric manipulation of these "hot spots" * an iterative in silico/in vitro strategy which helps define the structure activity relationship (SAR) at, or near, these biologically relevant "hot spots" * a family of "induced fit & structure optimized" lead stage molecules which can be further preclinically developed, or utilized by development partners to initiate more efficient and commercially relevant HTS strategies * an all encompassing breadth of associated biological IP, including targets, ligand families, and target specific biological processes which can be used by development partners for tremendous competitive advantage
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Sign in to CIENCE GO Data to uncover contact details
Free credits every month